Tag: Huang Peng
East & Concord advises in tumour-therapy licence win
China’s first commercial-use licensing of boron neutron capture therapy (BNCT) saw East & Concord Partners advising
LATEST ON VANTAGE ASIA
The A-List 2024-25: Visionaries
The A-List 2024-25: Legal leaders and influential lawyers in China's legal market
The A-List 2024-25: Visionaries
The A-List 2024-25: Legal leaders and influential lawyers in China's legal market
MOST READ ON VANTAGE ASIA
The A-List 2024-25: Visionaries
The A-List 2024-25: Legal leaders and influential lawyers in China's legal market
The A-List 2024-25: Visionaries
The A-List 2024-25: Legal leaders and influential lawyers in China's legal market
